Records containing: Lipid Metabolism, Inborn Errors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-06-11A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With a History of HeFH Who Are Not Adequately Controlled by Their Lipid Modifying Therapies
-
CLINICAL_TRIALS study record update · 2024-09-19A Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL Metabolism
-
CLINICAL_TRIALS study record update · 2024-08-15A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK0653 When Added to Current Regimen in Patients With Homozygous Sitosterolemia - 1 Year Open-Label Extension
-
CLINICAL_TRIALS study record update · 2024-08-15A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK0653 When Added to Current Regimen in Patients With Homozygous Sitosterolemia
-
CLINICAL_TRIALS study record update · 2024-08-15An Open-Label, Worldwide, Treatment Use Study to Provide Ezetimibe 10 Mg/Day to Patients With Homozygous Familial Hypercholesterolemia or Homozygous Sitosterolemia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-08-15A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to An Ongoing Regimen of Ezetimibe 10 mg in Patients Homozygous Sitosterolemia
-
CLINICAL_TRIALS study record update · 2019-10-16Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
-
CLINICAL_TRIALS study record update · 2019-05-24Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
-
CLINICAL_TRIALS study record update · 2016-03-15Immunization Against oxLDL in Patients With Lysosomal Lipid Diseases and Associated Metabolic Disorders
-
CLINICAL_TRIALS study record update · 2015-12-21An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2015-06-24A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Apolipoprotein B(ApoB) Reduction by ISIS 301012 on Liver Triglyceride Content in Subjects With Varying Degrees of Hyperlipidemia
-
CLINICAL_TRIALS study record update · 2013-04-05An Open-Label Extension Study to Assess the Long-term Safety and Efficacy of Mipomersen in Subjects With Familial Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2013-03-21A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Mipomersen as Add-on Therapy in Homozygous Familial Hypercholesterolemia Subjects